Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 5.32574 | 78 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 5.34495 | 78 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 5.34856 | 78 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 5.29928 | 76 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 5.28407 | 77 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 5.24113 | 78 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.85622 | 75 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 5.22272 | 77 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 5.3363 | 78 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 5.36866 | 78 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 5.33789 | 78 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 5.34224 | 77 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 5.33815 | 78 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 5.37415 | 78 |